Performance of a Real-Time PCR Assay for the Detection of Five Candida Species in Blood Samples from ICU Patients at Risk of Candidemia

Carregando...
Imagem de Miniatura
Citações na Scopus
1
Tipo de produção
article
Data de publicação
2023
Título da Revista
ISSN da Revista
Título do Volume
Editora
MDPI
Citação
JOURNAL OF FUNGI, v.9, n.6, article ID 635, 12p, 2023
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
The gold standard for diagnosing invasive candidiasis still relies on blood cultures, which are inefficient and time-consuming to analyze. We developed an in-house qPCR assay to identify the 5 major Candida species in 78 peripheral blood (PB) samples from ICU patients at risk of candidemia. Blood cultures and (1,3)-beta-D-glucan (BDG) testing were performed concurrently to evaluate the performance of the qPCR. The qPCR was positive for DNA samples from all 20 patients with proven candidemia (positive PB cultures), showing complete concordance with Candida species identification in blood cultures, except for detection of dual candidemia in 4 patients, which was missed by blood cultures. Additionally, the qPCR detected Candida species in six DNA samples from patients with positive central venous catheters blood (CB) but negative PB cultures. BDG values were similarly high in these six samples and the ones with proven candidemia, strongly suggesting the diagnosis of a true candidemia episode despite the negative PB cultures. Samples from patients neither infected nor colonized yielded negative results in both the qPCR and BDG testing. Our qPCR assay was at least as sensitive as blood cultures, but with a shorter turnaround time. Furthermore, negative results from the qPCR provided strong evidence for the absence of candidemia caused by the five major Candida species.
Palavras-chave
molecular diagnosis, real-time PCR, candidemia, Candida, 1,3-beta-D-glucan
Referências
  1. Agnelli C, 2022, LANCET REG HEALTH-AM, V6, DOI 10.1016/j.lana.2021.100117
  2. Alves J, 2022, ANTIBIOTICS-BASEL, V11, DOI 10.3390/antibiotics11121804
  3. Arendrup MC, 2019, OPEN FORUM INFECT DI, V6, DOI 10.1093/ofid/ofz136
  4. Arvanitis M, 2014, J CLIN MICROBIOL, V52, P3731, DOI 10.1128/JCM.01365-14
  5. Arvanitis M, 2014, CLIN MICROBIOL REV, V27, P490, DOI 10.1128/CMR.00091-13
  6. Avni T, 2011, J CLIN MICROBIOL, V49, P665, DOI 10.1128/JCM.01602-10
  7. Babb J, 2022, MICROBIOL SPECTR, DOI 10.1128/spectrum.00228-22
  8. Bassetti M, 2021, CLIN INFECT DIS, V72, pS121, DOI 10.1093/cid/ciaa1751
  9. Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797
  10. Calandra T, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1313-6
  11. Camp I, 2020, J FUNGI, V6, DOI 10.3390/jof6030101
  12. Clancy CJ, 2019, CURR OPIN INFECT DIS, V32, P546, DOI 10.1097/QCO.0000000000000594
  13. Clancy CJ, 2018, CLIN INFECT DIS, V66, P1678, DOI 10.1093/cid/cix1095
  14. Clancy CJ, 2013, CLIN INFECT DIS, V56, P1284, DOI 10.1093/cid/cit006
  15. Colombo AL, 2014, INTENS CARE MED, V40, P1489, DOI 10.1007/s00134-014-3400-y
  16. Corcione S, 2022, DIAGNOSTICS, V12, DOI 10.3390/diagnostics12092124
  17. da Matta DA, 2017, J FUNGI, V3, DOI 10.3390/jof3020024
  18. de Almeida JN, 2016, MED MYCOL, V54, P885, DOI 10.1093/mmy/myw044
  19. Delaloye J, 2014, VIRULENCE, V5, P161, DOI 10.4161/viru.26187
  20. Doi AM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146909
  21. Duffy T, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000419
  22. Dupuis C, 2021, OPEN FORUM INFECT DI, V8, DOI 10.1093/ofid/ofab080
  23. Fernandez-Cruz A, 2014, MED MYCOL, V52, P489, DOI 10.1093/mmy/myu013
  24. Fortun J, 2014, J ANTIMICROB CHEMOTH, V69, P3134, DOI 10.1093/jac/dku225
  25. Georgacopoulos O, 2020, J CLIN MICROBIOL, V58, DOI 10.1128/JCM.00690-20
  26. Giacobbe D.R., 2015, CLIN MICROBIOL INFEC, V21, p954., DOI [10.1016/j.cmi.2015.06.002, DOI 10.1016/J.CMI.2015.06.002]
  27. Gill CM, 2019, DIAGN MICR INFEC DIS, V95, P162, DOI 10.1016/j.diagmicrobio.2019.04.016
  28. Hasseine L, 2015, J INFECTION, V71, P258, DOI 10.1016/j.jinf.2015.04.005
  29. Innings A, 2007, J CLIN MICROBIOL, V45, P874, DOI 10.1128/JCM.01556-06
  30. Kazancioglu S, 2022, J INFECT DEV COUNTR, V16, P362, DOI 10.3855/jidc.15711
  31. Kidd SE, 2020, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.02903
  32. Koc O, 2022, J FUNGI, V8, DOI 10.3390/jof8090972
  33. Kourkoumpetis TK, 2012, CLIN INFECT DIS, V54, P1322, DOI 10.1093/cid/cis132
  34. Kritikos A, 2020, J CLIN MICROBIOL, V58, DOI 10.1128/JCM.01996-19
  35. Kullberg BJ, 2015, NEW ENGL J MED, V373, P1445, DOI 10.1056/NEJMra1315399
  36. Lamoth F, 2020, OPEN FORUM INFECT DI, V7, DOI 10.1093/ofid/ofaa075
  37. Lau A, 2008, J CLIN MICROBIOL, V46, P3021, DOI 10.1128/JCM.00689-08
  38. Liu Y, 2015, J CLIN MICROBIOL, V53, P3017, DOI 10.1128/JCM.00673-15
  39. Lopez-Medrano F, 2012, DIAGN MICR INFEC DIS, V73, P157, DOI 10.1016/j.diagmicrobio.2012.03.002
  40. Luciano P, 2007, FORENSIC SCI INT-GEN, V1, P262, DOI 10.1016/j.fsigen.2007.06.003
  41. McKeating C, 2018, J CLIN PATHOL, V71, P420, DOI 10.1136/jclinpath-2017-204692
  42. Mennink-Kersten MASH, 2008, CLIN INFECT DIS, V46, P1930, DOI 10.1086/588563
  43. Mikulska M, 2016, CLIN MICROBIOL INFEC, V22, DOI 10.1016/j.cmi.2016.05.020
  44. Mikulska M, 2022, J FUNGI, V8, DOI 10.3390/jof8090921
  45. Mikulska M, 2010, CRIT CARE, V14, DOI 10.1186/cc9365
  46. Mylonakis E, 2015, CLIN INFECT DIS, V60, P892, DOI 10.1093/cid/ciu959
  47. Nguyen MH, 2012, CLIN INFECT DIS, V54, P1240, DOI 10.1093/cid/cis200
  48. Nieto M, 2019, INFECT DIS THER, V8, P429, DOI 10.1007/s40121-019-0248-z
  49. Pappas PG, 2016, CLIN INFECT DIS, V62, pE1, DOI 10.1093/cid/civ933
  50. Pfaller MA, 2016, MED MYCOL, V54, P1, DOI 10.1093/mmy/myv076
  51. Pitarch A, 2018, CURR TOP MED CHEM, V18, P1375, DOI 10.2174/1568026618666181025093146
  52. Price JS, 2022, J FUNGI, V8, DOI 10.3390/jof8090935
  53. Schell WA, 2012, EUR J CLIN MICROBIOL, V31, P2237, DOI 10.1007/s10096-012-1561-6
  54. Taira CL, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-406
  55. Terrero-Salcedo D, 2020, J CLIN MICROBIOL, V58, DOI 10.1128/JCM.01487-19
  56. White PL, 2021, CURR FUNGAL INFECT R, V15, P67, DOI 10.1007/s12281-021-00421-x
  57. White SK, 2020, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD009833.pub2, 10.1002/14551858.00009833.pub2]
  58. Zhang SX, 2021, J CLIN MICROBIOL, V59, DOI 10.1128/JCM.01784-20